Vaccine News and Research

Latest Vaccine News and Research

number of cases of most vaccine-preventable diseases is at an all-time low

A comparison of illness and death rates for 13 vaccine-preventable diseases in the U.S., before and after use of the vaccine, indicates there have been significant decreases in the number of cases, hospitalizations and deaths for each of the diseases examined, according to a study in the November 14 issue of JAMA: The Journal of the American Medical Association.

14 Nov 2007

La Jolla Institute for Allergy & Immunology to perform study on allergy molecular causes

A major study that will provide a new window into understanding and potentially treating allergies will be conducted by the La Jolla Institute for Allergy & Immunology (LIAI) under a $5 million federal contract.

14 Nov 2007

Volunteers in AIDS vaccine trial may be at greater risk of infection

Following the aborting of two international trials of an experimental AIDS vaccine, thousands of volunteers have been told the vaccine may have actually raised their risk of infection.

14 Nov 2007

Zinc transporters regulate pancreatic cancer

Zinc, an important trace element for healthy growth and development, can be related to pancreatic cancer. Too much ZIP4, a molecule that enables the transport of zinc into cells, promotes the growth and spread of pancreatic tumors cells, said a group of researchers from Baylor College of Medicine in Houston, The University of Texas M.D. Anderson Cancer Center and the University of Florida in Gainesville, in a report which appears online today in the Proceedings of the National Academy of Sciences.

13 Nov 2007

New genetic lineage of Ebola virus discovered in great apes

The Zaire species of Ebolavirus (ZEBOV) remains the most virulent of the various known species. It alone is responsible for 88% of human deaths from haemorrhagic fever recorded since Ebola's discovery in 1976.

13 Nov 2007

Most UK citizens susceptible to hep B infection

The failure of the UK to introduce universal hepatitis B immunisation means that most UK citizens are susceptible to infection, warns an infectious diseases expert in this week's BMJ.

13 Nov 2007

H5 avian influenza found on Suffolk poultry farm

The Department for the Environment Food and Rural Affairs (Defra) has confirmed avian influenza in turkeys on premises near Diss on the Norfolk/Suffolk border. Preliminary tests were positive for the H5 strain.

13 Nov 2007

Chicken pox vaccination should be introduced for children in the UK

The only realistic way of preventing deaths and severe complications arising from chickenpox is to routinely vaccinate children against the disease, concludes research published ahead of print in Archives of Disease in Childhood.

13 Nov 2007

Antivirals reduce deaths from flu in hospitalized patients

Adults with influenza infections serious enough to require hospitalization are much less likely to die from the disease if they are given antiviral medications, according to a new study published in the December 15 issue of Clinical Infectious Diseases, currently available online.

13 Nov 2007

Could a new vaccine be the key to stopping Alzheimer's disease?

A new study from the Oklahoma Medical Research Foundation (OMRF) shows that immunization could offer a way to blunt or even prevent the deadly, memory-robbing disease.

13 Nov 2007

Former Chair of Presidential Advisory Council on HIV/AIDS Hitt passes away

R. Scott Hitt -- a former HIV/AIDS physician and former chair of the Presidential Advisory Council on HIV/AIDS during the Clinton administration -- died Thursday of colon cancer at his home in West Hollywood, Calif., according to Hitt's friend and West Hollywood Mayor John Duran, the AP/San Francisco Chronicle reports.

12 Nov 2007

Seattle Post-Intelligencer examines reactions of people who participated in Merck's canceled HIV vaccine

The Seattle Post-Intelligencer on Friday examined the reaction of volunteers in the Seattle arm of Merck's recently halted HIV vaccine trial. According to the Post-Intelligencer, participants who were interviewed on the condition of anonymity have voiced "decidedly mixed feelings" about participating in the trial because of safety concerns (Paulson, Seattle Post-Intelligencer, 11/9).

12 Nov 2007